BackZevra Therapeutics Overview

Zevra Therapeutics Intangible Assets

Zevra Therapeutics's intangible assets is $5.8M.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$5.79M
17.92% YoYΔ $-1.26M vs prior year quarter

Peer average / median

Loading

Zevra Therapeutics Intangible Assets History

Loading

Zevra Therapeutics vs. peers: Intangible Assets Comparison

Loading

Zevra Therapeutics Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Zevra Therapeutics (ZVRA) FAQ

As of the most recent data (June 2026), ZVRA shows a intangible assets of $5.8M. That compares with $7.1M in the prior-year period — down 17.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ZVRA's intangible assets is now $5.8M (was $7.1M) — a 17.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Zevra Therapeutics is outperforming or lagging.

Tracking ZVRA's intangible assets over time shows whether Zevra Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $5.8M That compares with $7.1M in the prior-year period — down 17.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this intangible assets page, Stockcircle has Zevra Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect intangible assets (currently $5.8M) with ownership activity and broader fundamentals.

Zevra Therapeutics's intangible assets is $5.8M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.